In an unprecedented move, the FDA today granted accelerated approval to the cancer drug pembrolizumab (Keytruda – Merck & Co) for treatment of any unresectable or metastatic solid tumors associated with the genetic abnormality known as microsatellite instability. It’s the first time the agency approved a cancer treatment or indication that is not for a tumor
“Colon cancer patients who had a healthy body weight, engaged in regular physical activity … and drank small to moderate amounts of alcohol had longer disease-free and overall survival than patients who did not,” Erin L. Van Blarigan, ScD, of the University of California San Francisco said during a press briefing prior to the American
